Filing Details

Accession Number:
0001181431-11-028251
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-09 17:20:45
Reporting Period:
2011-05-05
Filing Date:
2011-05-09
Accepted Time:
2011-05-09 17:20:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Biosciences Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1324506 G David Ichikawa C/O Sangamo Biosciences Inc., Ste A-100
Point Richmond Tech Cntr, 501 Canal Blvd
Richmond CA 94804
Senior Vp, Bus. Dev. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-05 4,000 $5.19 4,000 No 4 M Direct
Common Stock Disposition 2011-05-05 4,000 $6.74 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2011-05-05 4,000 $0.00 4,000 $5.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,068 2014-12-19 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on or about March 11, 2011.
  2. Options vest as follows: (i) 25% of the option shares on December 20, 2005, and (ii) the remaining shares vest in a series of successive monthly installments over the remaining 36 months thereafter.